HC
Highmount Capital Portfolio holdings
AUM
$391M
Turnover
10.22%
1-Year Est. Return
2.65%
This Fund
S&P 500
This Quarter
Est. Return
+0.82%
1 Year Est. Return
+2.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$430M
AUM Growth
-$5.39M
(-1.2%)
Cap. Flow
-$9.46M
Cap. Flow
% of AUM
-2.2%
Top 10 Holdings %
Top 10 Hldgs %
44.95%
Holding
151
New
8
Increased
53
Reduced
50
Closed
6
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total World Stock ETF
VT
|
+$15.4M |
| 2 |
BlackRock Limited Duration Income Trust
BLW
|
+$3.95M |
| 3 |
Terex
TEX
|
+$3.03M |
| 4 |
Target
TGT
|
+$1.06M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Water Resources ETF
PHO
|
+$10.3M |
| 2 |
iShares MSCI All Country Asia ex Japan ETF
AAXJ
|
+$8.47M |
| 3 |
Tortoise Energy Infrastructure Corp
TYG
|
+$6.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.2M |
| 5 |
Fluor
FLR
|
+$1.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.66% |
| 2 | Financials | 10.63% |
| 3 | Technology | 8.08% |
| 4 | Industrials | 6.06% |
| 5 | Healthcare | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Gilead Sciences
GILD
$190B
| $282K | 0.07% |
3,980
| – | – |
2013 Q2
3 quarters
|
|
127
iShares MSCI KLD 400 Social ETF
DSI
$5.52B
| $281K | 0.07% |
8,000
| – | – |
2013 Q2
3 quarters
|
|
128
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
| $281K | 0.07% |
2,400
| – | – |
2013 Q2
3 quarters
|
|
129
Healthcare Services Group
HCSG
$1.44B
| $277K | 0.06% |
9,515
| – | – |
2013 Q3
2 quarters
|
|
130
DELISTED
Stericycle Inc
SRCL
| $272K | 0.06% |
2,395
| – | – |
2013 Q3
2 quarters
|
|
131
Walt Disney
DIS
$188B
| $271K | 0.06% |
3,383
+725
| +27% | +$56.2K |
2013 Q4
1 quarter
|
|
132
Mastercard
MA
$528B
| $265K | 0.06% |
3,550
| – | – |
2013 Q3
2 quarters
|
|
|
AGN
133
DELISTED
Allergan Inc
AGN
| $252K | 0.06% |
2,030
| – | – |
2013 Q4
1 quarter
|
|
134
Charles Schwab
SCHW
$167B
| $241K | 0.06% |
8,800
| – | – |
2013 Q4
1 quarter
|
|
135
Perrigo
PRGO
$2.21B
| $226K | 0.05% |
1,460
| – | – |
2013 Q4
1 quarter
|
|
136
L3Harris
LHX
$44.2B
| $223K | 0.05% |
3,050
| – | – |
2013 Q4
1 quarter
|
|
137
SPDR Gold Trust
GLD
$139B
| $218K | 0.05% |
1,770
-5,749
| -76% | -$717K |
2013 Q3
2 quarters
|
|
138
Zimmer Biomet
ZBH
$17.5B
| $217K | 0.05% |
+2,361
| New | +$218K |
2014 Q1
0 quarters
|
|
139
Mondelez International
MDLZ
$79.9B
| $215K | 0.05% |
+6,224
| New | +$213K |
2014 Q1
0 quarters
|
|
|
WFM
140
DELISTED
Whole Foods Market Inc
WFM
| $213K | 0.05% |
4,196
| – | – |
2013 Q3
2 quarters
|
|
141
Xylem
XYL
$24B
| $209K | 0.05% |
+5,737
| New | +$209K |
2014 Q1
0 quarters
|
|
142
Parker-Hannifin
PH
$121B
| $207K | 0.05% |
1,730
+117
| +7% | +$14K |
2013 Q4
1 quarter
|
|
143
Union Pacific
UNP
$170B
| $205K | 0.05% |
2,182
-250
| -10% | -$22.2K |
2013 Q4
1 quarter
|
|
|
CLR
144
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $205K | 0.05% |
+3,300
| New | +$188K |
2014 Q1
0 quarters
|
|
|
BFF
145
DELISTED
BFC FIN'L CP CL A
BFF
| $187K | 0.04% |
50,088
+3,719
| +8% | +$13.9K |
2013 Q2
3 quarters
|
|
146
Costco
COST
$435B
| – | – |
-1,697
| Closed | -$202K | – |
|
147
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| – | – |
-14,500
| Closed | -$606K | – |
|
148
iShares Russell 1000 Growth ETF
IWF
$127B
| – | – |
-20,300
| Closed | -$436K | – |
|
149
Polaris
PII
$2.88B
| – | – |
-1,400
| Closed | -$204K | – |
|
150
Templeton Emerging Markets Income Fund
TEI
$290M
| – | – |
-65,750
| Closed | -$901K | – |
|
Similar funds
GMCM
STI
RRC
CG
SCVF
F
R
SBK
Highmount Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Highmount Capital held 151 positions worth $430M, down 1.2% from $435M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Highmount Capital's Q1 2014 filing shows 8 new, 53 increased, 50 reduced and 6 closed positions. Its largest new stake was Vanguard Total World Stock ETF: 262,620 shares worth $15.7M. The largest sale was Invesco Water Resources ETF, an estimated $10.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Financials and Technology.
- Highmount Capital's largest Q1 2014 buy was Vanguard Total World Stock ETF: 262,620 shares worth $15.7M.
- Highmount Capital added most to Target in Q1 2014, an estimated $1.06M increase.
- Highmount Capital's biggest Q1 2014 reduction was Invesco Water Resources ETF, cutting an estimated $10.3M.
- Highmount Capital fully exited Templeton Emerging Markets Income Fund in Q1 2014, selling an estimated $901K.
- Highmount Capital's ten largest holdings make up 45% of its $430M portfolio in Q1 2014.
- Highmount Capital opened 8 new positions and closed 6 in Q1 2014.
- Highmount Capital's portfolio value fell 1.2% quarter-over-quarter to $430M.
Based on Highmount Capital's 13F filing for Q1 2014, filed 13 May 2014.